Medtronic (NYSE:MDT) issued an update on its FY20 earnings guidance on Thursday morning. The company provided earnings per share guidance of $5.44-5.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.43. Medtronic also updated its FY 2020 guidance to $5.44-5.50 EPS.
Shares of MDT stock opened at $91.64 on Friday. Medtronic has a fifty-two week low of $81.66 and a fifty-two week high of $100.15. The stock has a market cap of $117.71 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 2.18 and a beta of 0.78. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.92 and a current ratio of 2.36.
Medtronic (NYSE:MDT) last issued its quarterly earnings results on Thursday, May 23rd. The medical technology company reported $1.54 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.47 by $0.07. Medtronic had a return on equity of 13.85% and a net margin of 16.10%. The business had revenue of $8.15 billion for the quarter, compared to analyst estimates of $8.12 billion. During the same quarter in the previous year, the firm earned $1.42 earnings per share. The company’s revenue was up .0% on a year-over-year basis. Sell-side analysts predict that Medtronic will post 5.15 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Medtronic (MDT) Updates FY20 Earnings Guidance” was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.tickerreport.com/banking-finance/4351431/medtronic-mdt-updates-fy20-earnings-guidance.html.
Medtronic Company Profile
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.
Featured Story: What is a Lock-Up Period?
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.